AAPL303.12-30.31 (-9.09%) ▼|ABBV252.00-5.42 (-2.10%) ▼|ABT104.52-1.09 (-1.03%) ▼|ACN162.00-1.29 (-0.79%) ▼|ADBE243.69-4.21 (-1.70%) ▼|AMAT518.03+16.26 (+3.24%) ▲|AMD492.51+7.12 (+1.47%) ▲|AMGN382.14-5.50 (-1.42%) ▼|AMT171.62-2.85 (-1.63%) ▼|AMZN269.84+34.34 (+14.58%) ▲|AVGO382.83-5.01 (-1.29%) ▼|AXP337.24-0.28 (-0.08%) ▼|BA213.80-7.10 (-3.21%) ▼|BAC61.89+0.16 (+0.25%) ▲|BKNG193.11-0.13 (-0.07%) ▼|BLK1,095.18-3.20 (-0.29%) ▼|BMY64.17-0.69 (-1.06%) ▼|BNY156.40+0.32 (+0.21%) ▲|BRK-B509.00-0.68 (-0.13%) ▼|C132.91+0.59 (+0.45%) ▲|CAT815.88+6.74 (+0.83%) ▲|CL90.87-0.74 (-0.80%) ▼|CMCSA23.76+0.09 (+0.38%) ▲|COF208.31-1.83 (-0.87%) ▼|COP118.48-0.55 (-0.46%) ▼|COST948.28-5.89 (-0.62%) ▼|CRM180.42-0.29 (-0.16%) ▼|CSCO114.38+0.82 (+0.72%) ▲|CVS105.14-0.08 (-0.08%) ▼|CVX192.53+0.22 (+0.11%) ▲|DE594.35-5.12 (-0.85%) ▼|DHR193.94-2.24 (-1.14%) ▼|DIS96.13-0.03 (-0.03%) ▼|DUK126.01-0.27 (-0.21%) ▼|EMR148.98+0.34 (+0.23%) ▲|FDX308.43-0.13 (-0.04%) ▼|GD378.37-3.83 (-1.00%) ▼|GE357.34+2.30 (+0.65%) ▲|GEV993.42+11.44 (+1.17%) ▲|GILD129.60-1.69 (-1.28%) ▼|GM87.92-0.48 (-0.54%) ▼|GOOG347.05+13.37 (+4.01%) ▲|GOOGL347.51+13.85 (+4.15%) ▲|GS1,019.69-5.18 (-0.50%) ▼|HD330.22-3.13 (-0.94%) ▼|HON240.44-1.47 (-0.61%) ▼|IBM217.26-4.48 (-2.02%) ▼|INTC93.30+2.17 (+2.38%) ▲|INTU311.89-3.61 (-1.14%) ▼|ISRG350.70-2.27 (-0.64%) ▼|JNJ254.72-1.10 (-0.43%) ▼|JPM352.06+1.21 (+0.34%) ▲|KO87.68-0.81 (-0.92%) ▼|LIN478.23-30.41 (-5.98%) ▼|LLY1,125.96-29.02 (-2.51%) ▼|LMT572.71-1.40 (-0.24%) ▼|LOW208.04-2.04 (-0.97%) ▼|LRCX303.18+5.46 (+1.83%) ▲|MA568.75-8.60 (-1.49%) ▼|MCD268.44+0.00 (+0.00%) ▲|MDLZ62.78-0.30 (-0.48%) ▼|MDT84.24-1.48 (-1.72%) ▼|META546.68+7.65 (+1.42%) ▲|MMM175.40-0.67 (-0.38%) ▼|MO69.08+1.14 (+1.67%) ▲|MRK129.74-0.06 (-0.04%) ▼|MS210.96+2.05 (+0.98%) ▲|MSFT452.86+1.76 (+0.39%) ▲|MU851.13-23.53 (-2.69%) ▼|NEE87.73-0.20 (-0.23%) ▼|NFLX71.35-1.82 (-2.49%) ▼|NKE41.76-0.53 (-1.25%) ▼|NOW108.83-1.24 (-1.13%) ▼|NVDA197.00+1.96 (+1.00%) ▲|ORCL126.83-0.73 (-0.57%) ▼|PEP139.28-0.93 (-0.66%) ▼|PFE24.86-0.06 (-0.22%) ▼|PG142.54-1.42 (-0.99%) ▼|PLTR120.47-1.79 (-1.46%) ▼|PM191.84-0.16 (-0.08%) ▼|QCOM148.67-2.94 (-1.94%) ▼|RTX212.96-1.42 (-0.66%) ▼|SBUX105.09-0.76 (-0.72%) ▼|SCHW104.58+0.25 (+0.24%) ▲|SO94.70+0.36 (+0.38%) ▲|SPG230.40-0.04 (-0.02%) ▼|T23.44+0.23 (+0.97%) ▲|TMO566.39-10.38 (-1.80%) ▼|TMUS170.71-2.63 (-1.52%) ▼|TSLA304.78-4.07 (-1.32%) ▼|TXN276.92-1.84 (-0.66%) ▼|UBER69.67-0.71 (-1.00%) ▼|UNH417.25-4.23 (-1.00%) ▼|UNP290.90+1.44 (+0.50%) ▲|UPS104.45-0.82 (-0.78%) ▼|USB62.76-0.14 (-0.22%) ▼|V364.16-2.11 (-0.58%) ▼|VZ46.31+0.20 (+0.42%) ▲|WFC85.79+0.36 (+0.42%) ▲|WMT111.12+0.02 (+0.02%) ▲|XOM153.05-3.92 (-2.50%) ▼|AAPL303.12-30.31 (-9.09%) ▼|ABBV252.00-5.42 (-2.10%) ▼|ABT104.52-1.09 (-1.03%) ▼|ACN162.00-1.29 (-0.79%) ▼|ADBE243.69-4.21 (-1.70%) ▼|AMAT518.03+16.26 (+3.24%) ▲|AMD492.51+7.12 (+1.47%) ▲|AMGN382.14-5.50 (-1.42%) ▼|AMT171.62-2.85 (-1.63%) ▼|AMZN269.84+34.34 (+14.58%) ▲|AVGO382.83-5.01 (-1.29%) ▼|AXP337.24-0.28 (-0.08%) ▼|BA213.80-7.10 (-3.21%) ▼|BAC61.89+0.16 (+0.25%) ▲|BKNG193.11-0.13 (-0.07%) ▼|BLK1,095.18-3.20 (-0.29%) ▼|BMY64.17-0.69 (-1.06%) ▼|BNY156.40+0.32 (+0.21%) ▲|BRK-B509.00-0.68 (-0.13%) ▼|C132.91+0.59 (+0.45%) ▲|CAT815.88+6.74 (+0.83%) ▲|CL90.87-0.74 (-0.80%) ▼|CMCSA23.76+0.09 (+0.38%) ▲|COF208.31-1.83 (-0.87%) ▼|COP118.48-0.55 (-0.46%) ▼|COST948.28-5.89 (-0.62%) ▼|CRM180.42-0.29 (-0.16%) ▼|CSCO114.38+0.82 (+0.72%) ▲|CVS105.14-0.08 (-0.08%) ▼|CVX192.53+0.22 (+0.11%) ▲|DE594.35-5.12 (-0.85%) ▼|DHR193.94-2.24 (-1.14%) ▼|DIS96.13-0.03 (-0.03%) ▼|DUK126.01-0.27 (-0.21%) ▼|EMR148.98+0.34 (+0.23%) ▲|FDX308.43-0.13 (-0.04%) ▼|GD378.37-3.83 (-1.00%) ▼|GE357.34+2.30 (+0.65%) ▲|GEV993.42+11.44 (+1.17%) ▲|GILD129.60-1.69 (-1.28%) ▼|GM87.92-0.48 (-0.54%) ▼|GOOG347.05+13.37 (+4.01%) ▲|GOOGL347.51+13.85 (+4.15%) ▲|GS1,019.69-5.18 (-0.50%) ▼|HD330.22-3.13 (-0.94%) ▼|HON240.44-1.47 (-0.61%) ▼|IBM217.26-4.48 (-2.02%) ▼|INTC93.30+2.17 (+2.38%) ▲|INTU311.89-3.61 (-1.14%) ▼|ISRG350.70-2.27 (-0.64%) ▼|JNJ254.72-1.10 (-0.43%) ▼|JPM352.06+1.21 (+0.34%) ▲|KO87.68-0.81 (-0.92%) ▼|LIN478.23-30.41 (-5.98%) ▼|LLY1,125.96-29.02 (-2.51%) ▼|LMT572.71-1.40 (-0.24%) ▼|LOW208.04-2.04 (-0.97%) ▼|LRCX303.18+5.46 (+1.83%) ▲|MA568.75-8.60 (-1.49%) ▼|MCD268.44+0.00 (+0.00%) ▲|MDLZ62.78-0.30 (-0.48%) ▼|MDT84.24-1.48 (-1.72%) ▼|META546.68+7.65 (+1.42%) ▲|MMM175.40-0.67 (-0.38%) ▼|MO69.08+1.14 (+1.67%) ▲|MRK129.74-0.06 (-0.04%) ▼|MS210.96+2.05 (+0.98%) ▲|MSFT452.86+1.76 (+0.39%) ▲|MU851.13-23.53 (-2.69%) ▼|NEE87.73-0.20 (-0.23%) ▼|NFLX71.35-1.82 (-2.49%) ▼|NKE41.76-0.53 (-1.25%) ▼|NOW108.83-1.24 (-1.13%) ▼|NVDA197.00+1.96 (+1.00%) ▲|ORCL126.83-0.73 (-0.57%) ▼|PEP139.28-0.93 (-0.66%) ▼|PFE24.86-0.06 (-0.22%) ▼|PG142.54-1.42 (-0.99%) ▼|PLTR120.47-1.79 (-1.46%) ▼|PM191.84-0.16 (-0.08%) ▼|QCOM148.67-2.94 (-1.94%) ▼|RTX212.96-1.42 (-0.66%) ▼|SBUX105.09-0.76 (-0.72%) ▼|SCHW104.58+0.25 (+0.24%) ▲|SO94.70+0.36 (+0.38%) ▲|SPG230.40-0.04 (-0.02%) ▼|T23.44+0.23 (+0.97%) ▲|TMO566.39-10.38 (-1.80%) ▼|TMUS170.71-2.63 (-1.52%) ▼|TSLA304.78-4.07 (-1.32%) ▼|TXN276.92-1.84 (-0.66%) ▼|UBER69.67-0.71 (-1.00%) ▼|UNH417.25-4.23 (-1.00%) ▼|UNP290.90+1.44 (+0.50%) ▲|UPS104.45-0.82 (-0.78%) ▼|USB62.76-0.14 (-0.22%) ▼|V364.16-2.11 (-0.58%) ▼|VZ46.31+0.20 (+0.42%) ▲|WFC85.79+0.36 (+0.42%) ▲|WMT111.12+0.02 (+0.02%) ▲|XOM153.05-3.92 (-2.50%) ▼|
27.1 C
New York
Friday, July 31, 2026

Tag: oral

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar in adults with type 2 diabetes compared to...

Boralex Obtains Final Court Approval of the Arrangement with Brookfield and La Caisse

MONTRÉAL, June 05, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. ("Boralex" or the "Corporation") (TSX: BLX) announced today that the Corporation has obtained a final order from the Superior Court of Québec (Commercial Division) approving the previously-announced plan of arrangement under section 192 of the Canada Business Corporations Act (the "Arrangement") involving the Corporation and BIF Thunder Holdings Inc., a newly-formed entity to be jointly owned by Brookfield Infrastructure Fund V and/or its affiliates (collectively, "Brookfield") and Caisse de dépôt et placement du Québec. This final court approval follows the shareholder approval that was obtained at the annual and special meeting of the Corporation's shareholders held on Thursday, June 4, 2026.

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech),...

Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

New clinical findings further reinforce therapeutic potential of vapendavir as targeted approach to preventing rhinovirus-driven COPD exacerbationsWASHINGTON, June 5, 2026 /PRNewswire/ -- Altesa BioSciences, a...

Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval

NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors....

Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference

TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

13 Top Press Releases from May

Including United's offer for Spirit customers, eBay's response to GameStop's acquisition proposal, and a new partnership between major telecom providers.Plus, a recap of May's...

Boralex Announces Shareholder Approval of the Arrangement with Brookfield and La Caisse

MONTRÉAL, June 04, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. ("Boralex" or the "Corporation") (TSX: BLX) is pleased to announce that its shareholders have approved, at the annual and special meeting held on June 4, 2026 (the "Meeting"), a special resolution (the "Arrangement Resolution") approving the statutory plan of arrangement for the acquisition by BIF Thunder Holdings Inc., a newly-formed entity to be jointly owned by Brookfield Infrastructure Fund V and/or its affiliates (collectively, "Brookfield") and Caisse de dépôt et placement du Québec ("La Caisse"), of all the issued and outstanding Class A common shares of Boralex (the "Shares") at $37.25 in cash per Share (the "Arrangement").

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital
Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital

HelloNation Highlights Deep Cleaning for Gum Disease Prevention With Dental Expert Dr. John Morgan Jackson III, D.M.D.

The article outlines how deep cleaning and routine care address gum disease and protect long-term oral health.LAGRANGE, Ga., June 4, 2026 /PRNewswire/ -- Why...

Fusion Fuel Highlights Jaguar Uranium’s Surface Uranium-Copper-Vanadium Findings at Huemul Project; Planned Royal Uranium Acquisition Expected to Provide 1.0% NSR Royalty Exposure

Huemul Project is centered on Argentina’s first producing uranium mine; Jaguar reports visible surface mineralization, a potential 4-kilometer copper trend, first-ever sampling of historic mine dumps, and 200 rock samples submitted for assay

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026

BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target...

ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026

At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which will this year take part in Istanbul, Türkiye from 12 to 15 June 2026, the Danish pharmaceutical company ALK will present data and key insights within anaphylaxis, food and respiratory allergy.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOral